These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22720638)

  • 1. Combination of iCVD and porous silicon for the development of a controlled drug delivery system.
    McInnes SJ; Szili EJ; Al-Bataineh SA; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
    ACS Appl Mater Interfaces; 2012 Jul; 4(7):3566-74. PubMed ID: 22720638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive Coating.
    McInnes SJ; Szili EJ; Al-Bataineh SA; Vasani RB; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
    Langmuir; 2016 Jan; 32(1):301-8. PubMed ID: 26654169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide).
    McInnes SJ; Irani Y; Williams KA; Voelcker NH
    Nanomedicine (Lond); 2012 Jul; 7(7):995-1016. PubMed ID: 22394185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-dry synthesis and coating of methacrylic acid copolymers for controlled release.
    Lau KK; Gleason KK
    Macromol Biosci; 2007 Apr; 7(4):429-34. PubMed ID: 17429803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing pH-Responsive Biodegradable Polymer Coatings for Controlled Drug Release via Vapor-Based Route.
    Shi X; Ye Y; Wang H; Liu F; Wang Z
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):38449-38458. PubMed ID: 30360069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery.
    Bonanno LM; Segal E
    Nanomedicine (Lond); 2011 Dec; 6(10):1755-70. PubMed ID: 22122584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery.
    Liu D; Zhang H; Herranz-Blanco B; Mäkilä E; Lehto VP; Salonen J; Hirvonen J; Santos HA
    Small; 2014 May; 10(10):2029-38. PubMed ID: 24616278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porous silicon-poly(ε-caprolactone) film composites: evaluation of drug release and degradation behavior.
    Bodiford NK; McInnes SJP; Voelcker NH; Coffer JL
    Biomed Microdevices; 2018 Aug; 20(3):71. PubMed ID: 30097808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
    Jarvis KL; Barnes TJ; Prestidge CA
    Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
    Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
    Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.
    Nieto A; Hou H; Moon SW; Sailor MJ; Freeman WR; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1070-80. PubMed ID: 25613937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulus-responsiveness and drug release from porous silicon films ATRP-grafted with poly(N-isopropylacrylamide).
    Vasani RB; McInnes SJ; Cole MA; Jani AM; Ellis AV; Voelcker NH
    Langmuir; 2011 Jun; 27(12):7843-53. PubMed ID: 21604788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiated and oxidative chemical vapor deposition: a scalable method for conformal and functional polymer films on real substrates.
    Baxamusa SH; Im SG; Gleason KK
    Phys Chem Chem Phys; 2009 Jul; 11(26):5227-40. PubMed ID: 19551189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silicon in drug delivery applications.
    Salonen J; Kaukonen AM; Hirvonen J; Lehto VP
    J Pharm Sci; 2008 Feb; 97(2):632-53. PubMed ID: 17546667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatially Controlled Surface Modification of Porous Silicon for Sustained Drug Delivery Applications.
    Zhang DX; Yoshikawa C; Welch NG; Pasic P; Thissen H; Voelcker NH
    Sci Rep; 2019 Feb; 9(1):1367. PubMed ID: 30718670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and characterization of photoluminescent silicon nanoparticles for drug delivery applications.
    Ryu J; Cho B; Woo HG; Cho S; Sohn H
    J Nanosci Nanotechnol; 2013 Jan; 13(1):157-60. PubMed ID: 23646711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous silicon nanomaterials: recent advances in surface engineering for controlled drug-delivery applications.
    Zhang DX; Esser L; Vasani RB; Thissen H; Voelcker NH
    Nanomedicine (Lond); 2019 Dec; 14(24):3213-3230. PubMed ID: 31855121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in porous silicon technology for drug delivery.
    Barnes TJ; Jarvis KL; Prestidge CA
    Ther Deliv; 2013 Jul; 4(7):811-23. PubMed ID: 23883125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of porous silicon nanocarriers for parenteral peptide delivery.
    Kovalainen M; Mönkäre J; Kaasalainen M; Riikonen J; Lehto VP; Salonen J; Herzig KH; Järvinen K
    Mol Pharm; 2013 Jan; 10(1):353-9. PubMed ID: 23186283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.